Synthesis of two novel 3-Amino-5-[4-chloro-2-phenoxyphenyl]-4H-1,2,4-triazoles with Anticonvulsant activity

Iranian Journal of Pharmaceutical Research

Volumn 9, Issue 3, 2010, Pages 265-269

  Mahdavi, Mohammad ^a   Akbarzadeh, Tahmineh ^a   Sheibani, Vahid ^b   Abbasi, Maryam ^a   Firoozpour, Loghman ^a   Tabatabai, Sayyed Abbas ^c   Shafiee, Abbas ^d   Foroumadi, Alireza ^b,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticonvulsant; Benzodiazepine; Synthesis; Triazole

Indexed keywords

3 AMINO 5 (4 CHLORO 2 PHENOXYPHENYL) 4H 1,2,4 TRIAZOLE; 3 AMINO 5 [4 CHLORO 2 (2 FLUROPHENOXY)PHENYL] 4H 1,2,4 TRIAZOLE; DIAZEPAM; FLUMAZENIL; PENTETRAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; LETHAL DOSE; MALE; MOUSE; NONHUMAN;

EID: 78249265972     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Löscher W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharm. (1998) 342: 1-13.
2. Chen J, Sun XY, Chai KY, Lee JS, Song MS and Quan ZS. Synthesis and anticonvulsant evaluation of 4-(4-alkoxylphenyl)-3-ethyl-4H-1, 2, 4-triazoles as open-chain analogues of 7-alkoxyl-4, 5-dihydro[1,2,4]triazolo[4,3-a]quinolines. Bioorg. Med. Chem. (2007) 15: 6775-6781.
3. Karakurt A, Aytemir M D, Stables JP, Ozalp MF, Kaynak BS, Ozbey H and Dalkara S. Synthesis of some oxime ether derivatives of 1-(2-naphthyl)-2-(1,2,4-triazol-1-yl) ethanone and their anticonvulsant and antimicrobial activities. Arch. Pharm. Chem. Life Sci. (2006) 339: 513-520.
4. Guan LP, Jin QH, Tian GR, Chai KY and Quan ZS. Synthesis of some quinoline-2 (1H)-one and 1, 2, 4 - triazolo[4, 3 -a] quinoline derivatives as potent anticonvulsants. J. Pharm. Pharmaceut. Sci. (2007) 10: 254-262.
5. Akbarzadeh T, Tabatabai SA, Khoshnoud MJ, Shafaghi B and Shafiee A. Design and synthesis of 4H-3-(2-phenoxy) phenyl-1, 2, 4-triazole derivatives as benzodiazepine receptor agonists. Bioorg. Med. Chem. (2003) 11: 769-773.
6. Foroumadi A, Tabatabai SA, Gitinezhad G, Zarrindast MR and Shafiee A. Synthesis and anticonvulsant activity of 5-aryl-1, 3, 4-thiadiazole derivatives. Pharm. Pharmacol. Commun. (2000) 6: 31-33.
7. Zarghi A, Hajimahdi Z, Mohebbi S, Rashidi H, Mozaffari S, Sarraf S, Faizi M, Tabatabaee SA and Shafiee A. Design and synthesis of new 2-substituted-5-[2-(2-halobenzyloxy) phenyl]-1, 3, 4-oxadiazoles as anticonvulsant agents. Chem. Pharm. Bull. (2008) 56: 509-12.
8. Zarghi A, Faizi M, Shafaghi B, Ahadian A, Khojastehpoor HR, Zanganeh V, Tabatabai SA and Shafiee A. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazolesas benzodiazepine receptor agonists. Bioorg. Med. Chem. Lett. (2005) 15: 3126-9.
9. Shekarchi M, Binesh Marvasti M, Sharifzadeh M and Shafiee A. Anticonvulsant activities of 7-phenyl-5H-thiazolo [5, 4-e] [1, 2, 3, 4] tetrazolo [5, 1-c] pyrrolo [1, 2-a] [1,4] diazepine and 7-phenyl-5H-thiazolo [5, 4-e] [1,3,4] triazolo [5,1-c] pyrrolo [1, 2-a] [1, 4] diazepines. Iranian J. Pharm. Res. (2005) 4: 33-36.
10. Rineh A, Mahmoodi N, Abdolahi M, Foroumadi A, Sorkhi M and Shafiee A. Synthesis, analgesic and anti-inflammatory activity of 4-(2-phenoxyphenyl)semicarbazones. Arch. Pharm. (2007) 340: 409-415.
11. Shafiee A, Rineh A, Kebriaeezadeh A, Foroumadi A, Sheibani V and Afarinesh MR. Synthesis and anticonvulsant activity of 4-(2-phenoxyphenyl)semicarbazones. Med. Chem. Res. (2009) 18: 758-769.
12. Foroumadi A, Mirzaei M, Emami S, Salari P, Ghaffari F, Amini M and Shafiee A. Synthesis and antifungal activity of some new 1,2,4- triazole [3, 4-a] thiadiazine derivatives. Daru (2002) 10: 34-37.
13. Morpugo C. A new design of the screening of CNS-active drugs in mice (a multidimensional observation procedure and the study of pharmacological interactions). Arzneim. Forsch. (Drug Res.) (1971) 11: 1727-1734.